1992) and can also prevent splicing by binding to exonic
Among those uncovered was a protein with strong sequence similarity to SR proteins. Two forms of this proelements known as exonic splicing silencers (ESSs; retein, likely arising from alternative splicing, were recovviewed in Smith and Valcarcel, 2000) , although the ered. Strengthening the similarity with SR proteins, the mechanism(s) involved are not known. In Drosophila, RBD showed the highest homology with that of the clasthe P element somatic repressor (PSI) represses splicing sical SR protein SC35 (46% identity). Based on the by recruiting U1 snRNP to an upstream, psuedo 5Ј splice apparent size of the proteins, and in keeping with the site, preventing recognition of the authentic site (Lanaming system used for most SR proteins, we call bourier et al. GST fusion (not shown) proteins. Because of problems that is strongly activated by dephosphorylation. Sugwith solubility, we have not pursued studies with SRp38-2, gesting a possible physiological role for SRp38, we show and instead concentrated on full-length SRp38. Purified that the protein becomes dephosphorylated during M His-SRp38 was first used to produce rabbit anti-SRp38 phase of the cell cycle. We also show that splicing, antibodies, which were affinity purified with the SRp38 like other processes in gene expression, is inhibited in RBD. The purified antibodies were used to determine extracts prepared from mitotic cells. Under these condiSRp38 expression patterns in various mouse tissues tions, repression was found to be mediated by SRp38, and in HeLa cells. indicating that cell cycle-specific dephosphorylation of SRp38 is expressed in different tissues in distinct SRp38 plays a role in gene silencing during mitosis.
ways ( Figure 1C ). In ovary, testis, and uterus, both SRp38 and SRp38-2 are highly expressed, and at comResults parable levels. In brain and lung, on the other hand, SRp38 is strongly expressed, but SRp38-2 is barely deIsolation of SRp38 tectable. Neither protein is produced at significant levels Previous work from our lab has described properties of in heart, kidney, or liver. In all the expressing tissues, a the human splicing regulators Tra2␣ and Tra2␤ (Tacke et faint species could be detected with gel mobility slightly al., 1998). To extend these studies, we used a yeast twogreater than SRp38 (designated dSRp38), which we speculated might correspond to un-, or hypo-, phoshybrid screen to identify potential interacting proteins. The indicated amounts of baculovirus-produced SRp38 (His-SRp38) were added to HeLa NE (lanes 2-6) and S100 complemented with 250 ng of SC35 (lanes 8-11) together with a 32 P-labeled ␤-globin pre-mRNA. Products of splicing were analyzed by denaturing PAGE and autoradiography. Splicing intermediates and products are indicated schematically. (B) Potent inhibition of splicing by dSRp38. Increasing amounts of His-dSRp38 (2.5 ng to 10 ng) were incubated with NE (lanes 2-4) and with S100 complemented with 125 ng of SC35 (lanes 6-9). (C) Characterization of splicing inhibition by dSRp38. His-dSRp38 (4 or 10 ng) was added to splicing reactions as follows: untreated (lanes 2 and 3, respectively), CIP-treated and repurified (lanes 4 and 5), CIP-treated in the presence of ␤-glycerophosphate (␤) and repurified (lanes 6 and 7), and mock-treated in the presence of ␤ and repurified (lanes 8 and 9). (D) CIP treatment does not affect SC35-activated splicing. SC35 was added to splicing reactions in S100 extracts (lanes 1-3) or in NE (lanes 5-7) as follows: untreated (lanes 1 and 5), CIP-treated and repurified (lanes 2 and 6), and CIP-treated and repurified in the presence of ␤ (lanes 3 and 7). phorylated SRp38. To test this, and also to elucidate in fact repressed splicing of a human ␤-globin premRNA (or other substrates), either when added to NE SRp38 expression levels in HeLa cells, we performed or to S100 supplemented with SC35 or ASF/SF2 (Figure Western blots with HeLa whole-cell lysate, cytoplasmic 2A; results with other substrates and ASF/SF2 not extracts (S100), and nuclear extract either untreated (NE) shown). Although near-complete inhibition could be obor treated with calf intestinal phosphatase (NEϩCIP) served, relatively large amounts of recombinant protein ( Figure 1D ). The pattern of expression in HeLa cells was ‫005ف(‬ ng) were required, and the significance of this essentially identical to the mouse ovary/testis/uterus repression was therefore unclear (see also below). Simipattern. Like other SR proteins, SRp38 was not detected lar levels of repression were typically detected whether in S100. In NE, CIP treatment converted SRp38 to a form His-tagged SRp38 or GST-SRp38 (not shown) was emwith mobility identical to dSRp38, strongly suggesting ployed. However, some preparations of GST-SRp38 rethat this form in fact corresponds to dephosphorylated quired significantly less protein to achieve comparable SRp38.
repression, and this enhanced activity seemed to correlate with the presence of small amounts of a species SRp38 Is a Splicing Repressor Activated with SDS gel mobility that suggests that it might correby Dephosphorylation spond to unphosphorylated GST-SRp38. We next wished to determine whether SRp38 behaves In light of the above results, we tested directly whether like a typical SR protein; e.g., whether it can activate the phosphorylation status of SRp38 affects the prosplicing in extracts lacking SR proteins. Using an S100 tein's activity in splicing assays. Purified SRp38 was complementation assay, purified SRp38 (His-or GSTtreated with CIP and repurified ( Figure 1B ; see Experitagged) was unable to activate splicing of several differmental Procedures), and increasing amounts were ent pre-mRNAs (results not shown). However, during added to splicing reactions with NE or S100 plus SC35 ( Figure 2B ). Splicing inhibition was again observed, but the course of these experiments, we noticed that SRp38 strikingly, the amounts of dSRp38 required for full repression were greatly reduced. In both NE and S100, less than 10 ng resulted in complete inhibition, suggesting that dephosphorylated SRp38 was at least 50-fold more effective at splicing repression than was phosphorylated SRp38. Identical results (not shown) were obtained with two additional substrates, HIV-tat-and IgM H-chain-derived pre-mRNAs, suggesting that dSRp38 acts as a general splicing repressor.
Especially in light of the unexpected magnitude of the CIP-induced activation of splicing repression, it was essential to rule out the possibility that inhibition might have been due to an artifact of the CIP treatment. We therefore performed several control experiments to address this. In one, purified SRp38 was first incubated alone, with CIP, with CIP plus the phosphatase inhibitor ␤-glycerophosphate (␤), or with ␤ alone, and all four preparations of SRp38 were then repurified. Only the sample treated with CIP alone was dephosphorylated, as judged by SDS-PAGE (results not shown), and only this sample gave rise to splicing repression at the concentrations tested (4 and 10 ng; Figure 2C , lanes 4 and 5). In another experiment, SC35 (his-tagged, produced from recombinant baculovirus-infected cells) was incubated alone, with CIP, or with CIP plus ␤, and repurified Characteristics of dSRp38-Mediated in S100 extract plus SC35.
Splicing Repression
To gain insight into the mechanism by which dSRp38 inhibits splicing, we first determined at which step splictude higher than the concentration of dSRp38 required for inhibition (e.g., Figure 3B ). ing was blocked. To this end, we performed spliceosome assembly assays, utilizing the ␤-globin pre-mRNA Given that interactions with other SR proteins (which are mediated by RS domains) are not the basis of dSRp38 substrate and S100 extract activated with SC35, plus or minus 7.5 ng dSRp38. The results of a time course repression, it was conceivable that splicing inhibition was brought about by the RBD. To determine whether ( Figure 3A) show that this amount of dSRp38 is sufficient to prevent formation of complex A, which represents the SRp38 RBD was sufficient to repress splicing, we purified from E. coli fusion proteins containing the rethe earliest step in spliceosome assembly detectable by this method. We conclude that dSRp38 interferes lated RBDs from SRp38 and SC35, as well as from an hnRNP protein, hnRNP G. The proteins were added to with interactions involving early acting factors, such as U1 or U2 snRNP, branchsite recognition factors, and/ splicing reactions performed in S100 activated by SC35, and the results ( Figure 3C ) show that both the SRp38 or SR proteins.
We next examined whether dSRp38 activity involves and SC35 RBDs, but not the hnRNP G RBD, inhibited splicing, although only at high concentrations. Notably, interactions with SR protein splicing activators. This was tested first by asking whether increasing amounts of the amounts of either RBD and of full-length phosphorylated SRp38 (Figure 2A ) required for splicing inhibition SC35 could restore splicing inhibited by a small amount of dSRp38. The results ( Figure 3B) show that splicing were essentially identical. As full-length SC35 is a splicing activator, repression brought about by the inactive inhibition was not restored by increased levels of SC35, indicating that SR proteins are not the targets of dSRp38 SC35 RBD likely reflects competitive interactions that interfere with association of full-length SC35 with the repression activity. This is consistent with the fact that dSRp38 was found to interact at most weakly with other pre-mRNA. It is likely that the similar weak repression observed with both phosphorylated SRp38 and the iso-SR proteins in GST "pull-down"-type assays (although phosphorylated SRp38 interacts strongly; see Discuslated RBD reflect the same mechanism. Such "passive" repression, which was also described recently by Cowsion) (data not shown). Moreover, the amount of SR protein required to activate splicing is an order of magniper et al. (2001), may result only from the large excess To confirm that the species detected in the M phase lysates was in fact dSRp38, we analyzed by Western were used in splicing reactions, again with the ␤-globin Figure 5C) show that in the asynchronous cell extracts, CIP treatment that, while SRp38 and SRp38-2 were extracted equally at all salt concentrations, dSRp38 was not present in completely converted SRp38 to a more rapidly migrating form with identical mobility to the species detected in the 0.3 M extract, but fully extracted in the 2.0 M extract (compare with whole-cell lysate, Figure 5A ) and present M phase cells. Likewise, in M phase extracts, SRp38 was converted to the same rapidly migrating form, and at intermediate levels in the 0.6 M extract. To confirm and extend these results, we focused on the fact that no additional species were detected. (Blots with purified recombinant SRp38 and dSRp38 indicated the antibod-0.6 M NaCl gave an intermediate level of splicing inhibition and dSRp38 extraction. We therefore repeated the ies used in this experiment recognized dSRp38 ‫-2ف‬fold more efficiently than SRp38 [results not shown], and above experiment, except using 0.7 M NaCl for the intermediate salt concentration. Strikingly, splicing was sigtherefore, to facilitate comparisons of gel mobility, lower amounts of the CIP-treated extracts were analyzed.) nificantly more inhibited at 0.7 M than at 0.6 M ( Figure  6A ; compare ME1 and ME2) and dSRp38 was also more Quantitation of these and additional blots indicated that the amount of dSRp38 increased from about 2% of the efficiently extracted ( Figure 6B ). Together, these results provide a perfect correlation between splicing inhibition total SRp38 protein in asynchronous cells to 30% in mitotic cells.
in mitotic cell extracts and the presence of dSRp38.
dSRp38 Is Necessary for Mitotic Presence of dSRp38 Correlates with Splicing Inhibition Splicing Repression
The correlation between the presence of dSRp38 and The above results provided evidence that splicing is inhibited in mitotic cell extracts by (a) factor(s) extracted at mitotic splicing repression, coupled with the fact that SRp38 is abundant in HeLa cells ‫3ف(‬ ϫ 10 6 molecules high salt, and that SRp38 becomes dephosphorylated in M phase cells. If dSRp38 is responsible for M phase per cell; data not shown), strongly suggests that dSRp38 functions to repress the splicing machinery during mitosplicing repression, then it should be extracted from mitotic extracts at high salt but not at low salt. To test sis. Consistent with this, addition of classical SR proteins to mitotic extracts was unable to restore splicing this, we first examined extracts prepared as in Figure  4 , i.e., at 0.3, 0.6, and 2 M NaCl, both for splicing activity (results not shown), strengthening the conclusion that they are not inactivated during mitotis. But to provide ( Figure 6A ) and for the presence of dSRp38 ( Figure 6B) . As above, splicing was normal in the 0.3 M mitotic exmore conclusive evidence for the role of dSRp38, we wished to deplete repressed (i.e., high salt) mitotic examount of dSRp38 necessary to effect complete inhibition ‫4ف(‬ ng) was even less than observed with comparatracts of dSRp38 and to determine whether such a depleted extract becomes competent for splicing. Our inible asynchronous extract ‫5.7ف(‬ ng; see above). Addition of phosphorylated SRp38 or other SR proteins (e.g., tial attempts to do this using anti-SRp38 antibodies were unsuccessful, as we were unable to deplete the protein ASF/SF2) was without effect (Figure 7D ), confirming that inhibition was specific to dSRp38. efficiently (results not shown). We therefore decided to attempt to deplete the SRp38 proteins by another approach, RNA affinity. This method has been used before, Discussion for example, to deplete the abundant hnRNP A1 proteins from NE (Caputi et al., 1999) , but requires knowledge of The experiments presented here provide evidence that activation of a splicing repressor by dephosphorylation the protein's high-affinity RNA binding site. To determine this for SRp38, we performed SELEX (Tuerk and is important in inhibition of the splicing machinery during M phase of the cell cycle. SRp38 thus behaves in a Gold, 1990) with the GST-SRp38 RBD protein (see Experimental Procedures; Y. Feng, C.S., and J.L.M., undistinctive manner, unlike previously characterized SR proteins. Below we discuss the features of SRp38 that published). The consensus sequence that emerged was used to produce an 84 nucleotide biotinylated RNA conmight underlie these properties, the significance of mitotic splicing repression more generally, and finally the taining three copies of the consensus motif (bio-C3), and this was used to deplete SRp38 from mitotic extract role of dephosphorylation as an activating mechanism. SRp38 has an overall primary structure typical of SR by binding to avidin beads. Figure 7A displays a Western blot indicating that SRp38, dSRp38, and SRp38-2 were proteins, but its properties are quite atypical. Biochemically, SRp38 does not copurify with other SR proteins all depleted from the bio-C3-treated extract, but not from a mock-treated extract. Importantly, depletion was in the classical (NH 4 ) 2 SO 4 -MgCl 2 purification protocol (Zahler et al., 1992; our unpublished results). Functionspecific, as standard SR proteins were not significantly removed ( Figure 7A) . ally, other known SR proteins are individually able to activate splicing in extracts lacking SR proteins; SRp38 We next compared the splicing activity of the mockand bio-C3-depleted extracts with untreated mitotic exhas no detectable activating ability. The basis for these differences is currently unknown, but likely reflects diftract ( Figure 7B) . Strikingly, the bio-C3-depleted extract now displayed significant activity (lane 4), while the ferences in the RS domain. However, there is one property that we believe SRp38 likely shares with other SR mock (lane 3) and untreated (lane 2) extracts remained essentially inactive. To show that activation was due proteins, which is the ability to affect splicing both generally and in a sequence-specific manner. The general, specifically to removal of dSRp38, increasing amounts of dSRp38 were added to the bio-C3-depleted extract or sequence-independent, activation function of SR proteins, also referred to as exon-independent (Hertel and ( Figure 7C ). Splicing was again strongly repressed and, in keeping with the fact that dSRp38 was not quantitaManiatis, 1999), is driven by cooperative interactions involving RS domain-mediated interactions with other tively removed from the mitotic extract (Figure 7A) , the and -1, which correspond to SRp38 and SRp38-2, were isolated from a yeast two-hybrid screen with TLS/FUS sion mediated by SRp38, it is likely that similar principles underlie its mechanism of action. It has also been shown as bait (Yang et al., 1998 (Yang et al., , 2000 Figure 5B ). Both antisera were affinity purified with the SRp38 RBD coupled to Affirelies on numerous redundant components (e.g., SR 
